Abiopharma

News list

Bonvini Ezio 🟡 adjusted position in 0 shares (1 derivative) of MACROGENICS INC (MGNX) at $2.60 Transaction Date: Aug 17, 2026 | Filing ID: 000007

Full text

News bot Aug. 18, 2026, 8:53 p.m.
🔍 Bonvini Ezio (Executive)

Company: MACROGENICS INC (MGNX)

Report Date: 2026-08-17
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 40,000
- Total shares sold: 40,000
Detailed Transactions and Holdings:
- Acquired 40,000 shares of Common Stock at $2.6 per share (Direct)
  Date: 2026-08-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 185,799.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 40,000 shares of Employee Stock Option (right to buy) at $2.6 per share (Derivative)
  Date: 2026-08-17 | Code: M | Expires: 2035-02-07 | equity_swap_involved: 0 | shares_owned_after: 88,000.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: The transaction represents an exercise and hold of options.
- F2: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.